Adolor(ADLR)Maybe the Answer to the Pain of Owning Biotechs!

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Adolor(ADLR)Maybe the Answer to the Pain of Owning Biotechs!

An SI Board Since March 2003

Posts	SubjectMarks	Bans	Symbol
21	8	0	ADLR

Emcee: Arthur Radley	Type: Unmoderated

Introduction Market Data Compact

Adolor(ADLR) is an un-recognized biotech(IMO)that is working in the area of pain and gastrointestinal problems for peope undergoing abdominal surgery. Often patients undergoing surgery, they end of with bowel dysfunction because of the opiods use to control the pain.
ADLR has a drug(Alvimopan) that is Phase III testing for two major indications: post operative ilius and chronic opioid-induced bowel dysfunction. They have formed an alliance with Glaxo for this drug. Initial Phase III results should be out in the 1Q of 2003.

I welcome a discussion on the potential for this biotech. I do own a few shares in the company.

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
21	3 months delay. Sounds a bit more positive than a 3rd approvable letter. <b	idos	-	2/11/2008
20	<i>The stock is up 12% premarket</i> UPDATE 2-<b>Benefits tru	idos	-	1/24/2008
19	FDA Briefing paper for POI. fda.gov Proposed indication: “to accelerate the ti	kenhott	-	1/18/2008
18	RE: What do you think of the rest of Adolor's pipeline, namely the Delta pr	mcbio	-	4/11/2007
17	Well, that was painful. I was wrong about Entereg, but in reviewing the availabl	rareearth42	-	4/11/2007
16	So much for the partner and probably for Entereg... money.cnn.com	idos	-	4/10/2007
15	March 13 (Reuters) - Citi upgrades ADLR Current Rating Hold Price target $10	idos	-	3/13/2007
14	Adolor partner plans added Phase III study on its bowel drug Mon Mar 12, 2007 4:	idos	-	3/12/2007
13	It looks like this is going to go higher. Currently $7.26. Good luck! Tom	Tom Caruthers	-	1/13/2007
12	Stock has sunk down to $6.95. Currently on the bottom edge of narrowly expandin	Tom Caruthers	-	1/10/2007
11	Looks like ADLR will make its move up by the end of December. I have bought in	Tom Caruthers	-	11/28/2006
10	Hello Wilder, I see you've answered your question....I think efficacy for P	rareearth42	-	11/12/2006
9	RE42, you should listen to the call if you haven't already. It is only avai	keokalani'nui	-	11/10/2006
8	Hi Rare, I'm going to ask a really stupid question because I just can't	keokalani'nui	-	11/9/2006
7	ADLR is a good buy right now for a LTBH strategy because the FDA has probably ov	rareearth42	-	11/8/2006
6	FDA Issues Approvable Letter for Entereg(R) (alvimopan) for POI Monday November	kenhott	-	11/6/2006
5	>>LONDON and EXTON, Pa., March 7 /PRNewswire-FirstCall/ -- GlaxoSmithKline	tuck	-	3/7/2005
4	Satview LLC, Reno based broadband company, just completed its installation of ca	trueblood986	-	4/16/2003
3	Rating has jumped from 6 to 9 in past month.... Adolor Corporation: Stock Ratin	Arthur Radley	-	4/10/2003
2	Has been smooth sailing.....punching above the $14.00 level today.	Arthur Radley	-	4/4/2003
1	Interesting topic...undertreatment of cancer pain and the use of opioid....IMO t	Arthur Radley	-	3/8/2003

Go to reply# or date (mm/dd/yy):